222 related articles for article (PubMed ID: 21957493)
1. The stem cell patent landscape as relevant to cancer vaccines.
Wang SJ
Hum Vaccin; 2011 Oct; 7(10):1100-8. PubMed ID: 21957493
[TBL] [Abstract][Full Text] [Related]
2. Candida vaccines development from point view of US patent application.
Wang SJ
Hum Vaccin; 2011 Nov; 7(11):1165-71. PubMed ID: 22048114
[TBL] [Abstract][Full Text] [Related]
3. Herbal drug patenting in India: IP potential.
Sahoo N; Manchikanti P; Dey SH
J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
[TBL] [Abstract][Full Text] [Related]
4. The anatomy of medical school patenting.
Azoulay P; Michigan R; Sampat BN
N Engl J Med; 2007 Nov; 357(20):2049-56. PubMed ID: 18003961
[TBL] [Abstract][Full Text] [Related]
5. Linkage between research sponsorship and patented eye-care technology.
Ellwein LB; Kroll P; Narin F
Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2495-503. PubMed ID: 8933766
[TBL] [Abstract][Full Text] [Related]
6. Patent prosecution strategies for stem cell related applications.
Kumar R; Yeh JJ; Fernandez D; Hansen N
J Biomol Screen; 2007 Sep; 12(6):769-74. PubMed ID: 17848639
[TBL] [Abstract][Full Text] [Related]
7. Patenting of stem cells.
Williams G
Regen Med; 2006 Sep; 1(5):697-703. PubMed ID: 17465737
[TBL] [Abstract][Full Text] [Related]
8. Dendritic-cell-based technology landscape: Insights from patents and citation networks.
Kong X; Hu Y; Cai Z; Yang F; Zhang Q
Hum Vaccin Immunother; 2015; 11(3):682-8. PubMed ID: 25714961
[TBL] [Abstract][Full Text] [Related]
9. Patenting human pluripotent cells: balancing commercial, academic and ethical interests.
Bahadur G; Morrison M
Hum Reprod; 2010 Jan; 25(1):14-21. PubMed ID: 19897856
[TBL] [Abstract][Full Text] [Related]
10. Human induced pluripotent stem cells: a review of the US patent landscape.
Georgieva BP; Love JM
Regen Med; 2010 Jul; 5(4):581-91. PubMed ID: 20632861
[TBL] [Abstract][Full Text] [Related]
11. Patenting pluripotence: the next battle for stem cell intellectual property.
Vrtovec KT; Scott CT
Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018
[TBL] [Abstract][Full Text] [Related]
12. Patent trend and competitive analysis of cancer immunotherapy in the United States.
Pan CL; Chen FC
Hum Vaccin Immunother; 2017 Nov; 13(11):2583-2593. PubMed ID: 28881159
[TBL] [Abstract][Full Text] [Related]
13. Stem cell patents--reexamination/litigation--the last 5 years.
Shyntum Y; Kalkreuter E
Tissue Eng Part B Rev; 2009 Mar; 15(1):87-90. PubMed ID: 19260807
[TBL] [Abstract][Full Text] [Related]
14. Australian medical patents granted in the United States in 1984-1999.
Mattes E; Stacey MC
Med J Aust; 2001 Jan; 174(2):83-7. PubMed ID: 11245509
[TBL] [Abstract][Full Text] [Related]
15. Ethical questions to ponder in the European stem cell patent debate.
Curley D; Sharples A
J Biolaw Bus; 2006; 9(3):12-6. PubMed ID: 17152135
[TBL] [Abstract][Full Text] [Related]
16. The attack of the clones: patent law and stem cell research.
Rimmer M
J Law Med; 2003 May; 10(4):488-505. PubMed ID: 12852321
[TBL] [Abstract][Full Text] [Related]
17. Protecting new ideas and inventions in nanomedicine with patents.
Bawa R; Bawa SR; Maebius SB; Flynn T; Wei C
Nanomedicine; 2005 Jun; 1(2):150-8. PubMed ID: 17292072
[TBL] [Abstract][Full Text] [Related]
18. [Biotechnology research and generation of patents of interest to the health system].
Plaza Gómez L; Albert Martínez A
Med Clin (Barc); 2008 Dec; 131 Suppl 5():55-9. PubMed ID: 19631824
[TBL] [Abstract][Full Text] [Related]
19. Nanofiber patent landscape.
Ngiam M; Ramakrishna S; Raghunath M; Chan CK
Recent Pat Nanotechnol; 2007; 1(2):137-44. PubMed ID: 19076028
[TBL] [Abstract][Full Text] [Related]
20. Patent data mining: a tool for accelerating HIV vaccine innovation.
Clark K; Cavicchi J; Jensen K; Fitzgerald R; Bennett A; Kowalski SP
Vaccine; 2011 May; 29(24):4086-93. PubMed ID: 21496469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
